Novel antibiotic stewardship metrics and the quality of antibiotic prescribing for lower respiratory and urinary tract infection across 24 VA hospitals
Infection Control & Hospital Epidemiology · 2026-11 · 47 (11) · 1135-1141
DOI: 10.1017/ice.2026.10562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, online erschienen am 06.10.2026. Verfasst von Shungo Imai und 6 weiteren Autor:innen. Beteiligte Einrichtung: UI Carver College of Medicine: The University of Iowa Roy J and Lucille A Carver, USA. Hauptthemen laut MEDLINE: Urinary Tract Infections, Anti-Bacterial Agents, Hospitals, Veterans, Antimicrobial Stewardship. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Some inpatient antibiotic use metrics have important limitations, including the absence of patient-level risk adjustment. To address this limitation, we previously developed two risk-standardized ratios (RSRs), one based on days of therapy (RSR-DOT) and the other on days of antibiotic spectrum coverage (RSR-DASC). Here, we evaluated the construct validity of these metrics by examining whether hospital performance was associated with the quality of antibiotic selection and duration in patients with either lower respiratory tract infections (LRIs) or urinary tract infections (UTIs).
Methods
Using Veterans Health Administration data from October 2020 through September 2021, we calculated RSR-DOT and RSR-DASC for 121 acute-care hospitals and selected 24 hospitals with relatively low or high values. At each hospital, a blinded infectious diseases physician reviewed 10 admissions each for LRI and UTI. Antibiotic selection at day 3 and total antibiotic duration were adjudicated and summarized as a 6-category ordinal composite outcome. Associations between RSR metrics and antibiotic-prescribing quality were evaluated using ordinal logistic regression; model-fit and bootstrap analyses compared RSR-DOT and RSR-DASC.
Results
We reviewed 479 admissions (239 LRI and 240 UTI). In LRI, lower RSR-DASC tended to be associated with a higher quality of antibiotic use (coefficient, 2.906 [ P = .053]), whereas RSR-DOT was not (1.418 [ P = .374]). In UTI, neither metric was associated with the quality of antibiotic therapy. Model-fit and bootstrap analyses consistently favor RSR-DASC over RSR-DOT for LRI.
Conclusions
RSR-DASC may capture antibiotic-prescribing quality more closely than RSR-DOT for LRI, but not for UTI, potentially supporting the value of spectrum-informed benchmarking metrics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UI Carver College of Medicine: The University of Iowa Roy J and Lucille A Carver, USA.
- Iowa City VA Medical Center, USA.
- University of California San Diego Moores Cancer Center, USA.
ORCID-Profile: Shungo Imai, Daniel J Livorsi, Bruce Alexander
Zitieren
APA
Imai, S., Livorsi, D. J., Wright, T., Merchant, J., Cho, H., Alexander, B., & Goto, M. (2026). Novel antibiotic stewardship metrics and the quality of antibiotic prescribing for lower respiratory and urinary tract infection across 24 VA hospitals. Infection Control & Hospital Epidemiology, 47(11), 1135-1141. https://doi.org/10.1017/ice.2026.10562
Vancouver
Imai S, Livorsi DJ, Wright T, Merchant J, Cho H, Alexander B, et al. Novel antibiotic stewardship metrics and the quality of antibiotic prescribing for lower respiratory and urinary tract infection across 24 VA hospitals. Infection Control & Hospital Epidemiology. 2026;47(11):1135-1141. doi:10.1017/ice.2026.10562
BibTeX
@article{Imai2026,
author = {Imai, Shungo and Livorsi, Daniel J and Wright, Thomas and Merchant, James and Cho, Hyunkeun and Alexander, Bruce and Goto, Michihiko},
title = {Novel antibiotic stewardship metrics and the quality of antibiotic prescribing for lower respiratory and urinary tract infection across 24 VA hospitals},
journal = {Infection Control & Hospital Epidemiology},
year = {2026},
volume = {47},
number = {11},
pages = {1135--1141},
doi = {10.1017/ice.2026.10562}
}
EUVIMED